These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 22788366)

  • 1. Everolimus enhances gemcitabine-induced cytotoxicity in bladder-cancer cell lines.
    Pinto-Leite R; Arantes-Rodrigues R; Palmeira C; Gaivão I; Cardoso ML; Colaço A; Santos L; Oliveira P
    J Toxicol Environ Health A; 2012; 75(13-15):788-99. PubMed ID: 22788366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic potential of sepantronium bromide YM155 in gemcitabine-resistant human urothelial carcinoma cells.
    Huang YT; Cheng CC; Lin TC; Chiu TH; Lai PC
    Oncol Rep; 2014 Feb; 31(2):771-80. PubMed ID: 24297644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Temsirolimus improves cytotoxic efficacy of cisplatin and gemcitabine against urinary bladder cancer cell lines.
    Pinto-Leite R; Arantes-Rodrigues R; Ferreira R; Palmeira C; Colaço A; Moreira da Silva V; Oliveira P; Lara Santos L
    Urol Oncol; 2014 Jan; 32(1):41.e11-22. PubMed ID: 24035472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Everolimus and mycophenolate mofetil sensitize human pancreatic cancer cells to gemcitabine in vitro: a novel adjunct to standard chemotherapy?
    Tuncyurek P; Mayer JM; Klug F; Dillmann S; Henne-Bruns D; Keller F; Stracke S
    Eur Surg Res; 2007; 39(6):380-7. PubMed ID: 17700025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased drug resistance of bladder cancer using phytochemicals treatment.
    Cho CJ; Yu CP; Wu CL; Ho JY; Yang CW; Yu DS
    Kaohsiung J Med Sci; 2021 Feb; 37(2):128-135. PubMed ID: 33280258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo and in vitro effects of RAD001 on bladder cancer.
    Vasconcelos-Nóbrega C; Pinto-Leite R; Arantes-Rodrigues R; Ferreira R; Brochado P; Cardoso ML; Palmeira C; Salvador A; Guedes-Teixeira CI; Colaço A; Palomino LF; Lopes C; Santos L; Oliveira PA
    Urol Oncol; 2013 Oct; 31(7):1212-21. PubMed ID: 22169072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lentinan reduces tumor progression by enhancing gemcitabine chemotherapy in urothelial bladder cancer.
    Sun M; Zhao W; Xie Q; Zhan Y; Wu B
    Surg Oncol; 2015 Mar; 24(1):28-34. PubMed ID: 25434982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gemcitabine impacts differentially on bladder and kidney cancer cells: distinct modulations in the expression patterns of apoptosis-related microRNAs and BCL2 family genes.
    Papadopoulos EI; Yousef GM; Scorilas A
    Tumour Biol; 2015 May; 36(5):3197-207. PubMed ID: 25833690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of checkpoint kinase 1 potentiates anticancer activity of gemcitabine in bladder cancer cells.
    Isono M; Okubo K; Asano T; Sato A
    Sci Rep; 2021 May; 11(1):10181. PubMed ID: 33986399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 1,25D3 enhances antitumor activity of gemcitabine and cisplatin in human bladder cancer models.
    Ma Y; Yu WD; Trump DL; Johnson CS
    Cancer; 2010 Jul; 116(13):3294-303. PubMed ID: 20564622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Schedule-dependent cytotoxic interaction between epidoxorubicin and gemcitabine in human bladder cancer cells in vitro.
    Zoli W; Ricotti L; Tesei A; Ulivi P; Gasperi Campani A; Fabbri F; Gunelli R; Frassineti GL; Amadori D
    Clin Cancer Res; 2004 Feb; 10(4):1500-7. PubMed ID: 14977854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of caspase mediated apoptosis and down-regulation of nuclear factor-κB and Akt signaling are involved in the synergistic antitumor effect of gemcitabine and the histone deacetylase inhibitor trichostatin A in human bladder cancer cells.
    Jeon HG; Yoon CY; Yu JH; Park MJ; Lee JE; Jeong SJ; Hong SK; Byun SS; Lee SE
    J Urol; 2011 Nov; 186(5):2084-93. PubMed ID: 21944112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro synergistic cytotoxicity of gemcitabine and pemetrexed and pharmacogenetic evaluation of response to gemcitabine in bladder cancer patients.
    Mey V; Giovannetti E; De Braud F; Nannizzi S; Curigliano G; Verweij F; De Cobelli O; Pece S; Del Tacca M; Danesi R
    Br J Cancer; 2006 Aug; 95(3):289-97. PubMed ID: 16868547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic antitumour effects of triptolide plus gemcitabine in bladder cancer.
    Yang Y; Zhang LJ; Bai XG; Xu HJ; Jin ZL; Ding M
    Biomed Pharmacother; 2018 Oct; 106():1307-1316. PubMed ID: 30119201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Olive Mill Wastewater Inhibits Growth and Proliferation of Cisplatin- and Gemcitabine-Resistant Bladder Cancer Cells In Vitro by Down-Regulating the Akt/mTOR-Signaling Pathway.
    Rutz J; Maxeiner S; Juengel E; Chun FK; Tsaur I; Blaheta RA
    Nutrients; 2022 Jan; 14(2):. PubMed ID: 35057550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequential gemcitabine and tamoxifen treatment enhances apoptosis and blocks transformation in bladder cancer cells.
    Takeuchi H; Mmeje CO; Jinesh GG; Taoka R; Kamat AM
    Oncol Rep; 2015 Nov; 34(5):2738-44. PubMed ID: 26323344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toxicogenomic activity of gemcitabine in two TP53-mutated bladder cancer cell lines: special focus on cell cycle-related genes.
    da Silva GN; de Camargo EA; Salvadori DM
    Mol Biol Rep; 2012 Dec; 39(12):10373-82. PubMed ID: 23053941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The flavonoid apigenin potentiates the growth inhibitory effects of gemcitabine and abrogates gemcitabine resistance in human pancreatic cancer cells.
    Strouch MJ; Milam BM; Melstrom LG; McGill JJ; Salabat MR; Ujiki MB; Ding XZ; Bentrem DJ
    Pancreas; 2009 May; 38(4):409-15. PubMed ID: 19142175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gemcitabine-induced apoptosis in 5637 cell line: an in-vitro model for high-risk superficial bladder cancer.
    Gazzaniga P; Silvestri I; Gradilone A; Scarpa S; Morrone S; Gandini O; Gianni W; Frati L; Aglianò AM
    Anticancer Drugs; 2007 Feb; 18(2):179-85. PubMed ID: 17159604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of hyperthermia on the cytotoxicity of 4 chemotherapeutic agents currently used for the treatment of transitional cell carcinoma of the bladder: an in vitro study.
    van der Heijden AG; Verhaegh G; Jansen CF; Schalken JA; Witjes JA
    J Urol; 2005 Apr; 173(4):1375-80. PubMed ID: 15758808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.